N-(3-morpholin-4-ylpropyl)-1,3-benzothiazol-2-amine, 95.0%, 1g

Repaglinide>98.0%(HPLC)(T)200mg

Ammonium Thiocyanate>98.0%(T)25g

Butyl Formate>95.0%(GC)25mL

4-[(2-hydroxyethyl)(methyl)amino]benzoic acid, 95.0%, 25g

Infinity corrected plan PL-M 20x/0.40 IOS objective. Working distance 7.8 mm. No cover glass correction

2-Methyl-5-nitro-1H-benzoimidazole, 95.0%, 5g

3,4-Dimethoxyiodobenzene, 95.0%, 5g

3-(Naphthalen-2-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde, 97.0%, 1g

Methyl 2-chloro-5-fluoro-3-(trifluoromethyl)benzoate, 95%, 1g

2-Hydroxy-1,2-di(thiophen-2-yl)ethan-1-one, 97%, 5g

GC capillary column ROTI®Cap-FFAP, 30 m, 0.53 mm, 0.50 µm, 1 Piece(s)

Disodium tetraborate decahydrate, min. 99%, Ph.Eur., BP, NF, 2.5 kg, plastic packaging.